Anonymous
Guest
Anonymous
Guest
It might be a nuisance lawsuit but even then it makes only a little sense from that perspective given that Bovie isn't exactly seen these days as a paragon of thought leadership and execution. The technology is fine but both Salient and Bovie seem to be companies that can't get out of their own way. Salient still wants to be US Surgical (even though it’s been borne out that being US Surgical almost killed US Surgical) and Bovie is doing “me-too” products under the premise that vessel sealing and saline surgery are new and ground-breaking technologies, not to mention the J-Plasma that has been right around the corner for the last five years.